|
IONS | Ionis Pharmaceuticals Inc |
|
|
IONS | Ionis Pharmaceuticals Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.05 |
| Leverage | 86.12% |
| Market Cap | $ 10.2B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -378.6m |
| Margin | -40.83% |
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.